Doctors that prescribe peptides
How does an online visit turn into a legitimate prescription? These articles walk through it: what happens in an intake, why doctors that prescribe peptides online must be licensed in your state, how compounding pharmacies fill orders, and what to expect from your first visit.
If you've only seen peptides sold with no questions asked, this topic explains what the doctor-in-the-loop model changes — including that not everyone qualifies. Every state is different, and the licensure article explains why that matters more than most people expect.
73 articles on this topic
-
Should I Take Semaglutide? How a Provider Decides
A BMI of 32 can open the conversation. Medical history, current medicines and a workable follow-up plan determine where it goes.
-
Who Discovered Kisspeptin? The People Behind It
Danny Welch's cancer research started the story in 1996. Other teams found the peptide, connected it to puberty, and brought it into human studies.
-
FDA Category 2 Bulk Drug Substances: What It Means
Category 2 means FDA has identified significant safety concerns about a nominated compounding ingredient. Here is what the category tells a patient, and why leaving it does not mean approval.
-
Gray Market Peptides: What Johns Hopkins Found
Johns Hopkins says the market for unverified peptide vials is growing much faster than the human evidence. The useful question is what a prescription and a pharmacy change.
-
Forzinity Approval: One Year Later
On September 19, 2025, Forzinity became the first treatment for Barth syndrome through accelerated approval. A year later, that narrow decision still rests on a required confirmatory trial.
-
Is GHK-Cu FDA Approved? No, Its Review Is Pending
GHK-Cu is not FDA-approved. Its compounding review separates non-injectable use from injections, and the next advisory meeting still has no specific date.
-
10 Questions to Ask Doctor About Tirzepatide
A tirzepatide visit is mostly about fit: the provider needs a clear picture of medical history, medicines, pregnancy plans, digestion, and upcoming procedures. These ten questions explain what matters and why.
-
FDA Tentative Approval: What It Means
FDA tentative approval means an application has cleared the scientific review needed for approval, but a legal barrier still prevents U.S. marketing. It is a real milestone, not permission to sell the drug.
-
Semax FDA History: What the July Vote Changed
Semax has never had an FDA-approved U.S. product. A July 2026 advisory vote supported possible 503A listing, but it did not add Semax to the list or approve a drug.
-
Kisspeptin Supplement: A Capsule Isn't the Peptide
A capsule sold as a kisspeptin supplement does not deliver the peptide used in the hormone and fertility studies people usually quote. Those studies used a vein or an injection under the skin, not an ordinary pill.
-
PT-141 10mg Vial: What That Number Means
Ten milligrams describes what is in the whole vial. It does not tell you what to draw up, how many uses you have, or how a nasal product compares; those answers come from the prescription and pharmacy label.
-
FDA Telehealth Compounded Drugs: 5 Red Flags
FDA says telehealth sites must not present a compounded drug as a generic, a brand equivalent, or an agency-reviewed product. Here is what an honest prescription page should make clear.
-
Generic Semaglutide Exists—Just Not in the U.S.
Canada now has authorized semaglutide generics. The U.S. has only a tentative approval, while compounded semaglutide is another category altogether.
-
Is Tesamorelin a Steroid? No—It's a GHRH Peptide
Tesamorelin is a peptide signal, not an anabolic steroid or growth hormone itself. It prompts the pituitary to release growth hormone, but sport rules still prohibit it.
-
Kisspeptin vs PT-141: They Work Differently
Kisspeptin and PT-141 both enter libido conversations, but they act on different systems and do not share the same evidence. PT-141 has larger trials and an approved branded product; kisspeptin's human data are smaller and earlier.
-
Retatrutide Early Access Is Real—and Very Limited
Retatrutide early access now exists through a narrow, doctor-led program. It is not a public prescription route, a sale, or an approval.
-
There Is No Best BPC-157 Brand. Ask This Instead.
No company holds an approval to make BPC-157, so the “brands” ranked online are websites, not manufacturers. What's worth comparing is the pharmacy and the prescription behind the vial.
-
Compounded Medication Recall: Check the Lot
A recall usually applies to one pharmacy, one preparation and specific lot numbers—not every compounded medication. Here is how to check a vial and reach the people responsible for it.
-
Kisspeptin-54 vs Kisspeptin-10: Why Length Matters
Kisspeptin-54 is the whole peptide; kisspeptin-10 is its last ten amino acids. The long one lasts about seven times longer in the blood, and that one fact explains which studies used which.
-
Tesamorelin Cost: Brand vs. Compounded Prices
Public brand benchmarks run from about $6,000 a month at wholesale list price to roughly $10,709 for a 28-day cash quote. Insurance may bring that down for HIV-associated lipodystrophy; compounded tesamorelin follows a separate cash-pay path.
Page 1 of 4 · 73 articles